Company news
Oryzon Genomics SA news in 2015
Oryzon Genomics SA's news releases, calls and decks from 2015, newest first.
Oryzon Genomics Receives 1.3M USD Public Aids to Advance Development of its Epigenetic Inhibitors
December 30, 2015
ORYZON Files Clinical Trial Application in Spain for Phase I Study With ORY-2001 for Alzheimer’s Disease
December 16, 2015
Oryzon Genomics Announces Listing on Madrid Stock Exchange
December 10, 2015
ORYZON Announces the Appointment of Mr. Antonio Fornieles, Ms. Isabel Aguilera and Mr. Ramon Adell as Independent Directors
November 4, 2015
Oryzon Announces Oral Presentation on ORY-2001 at 8th Annual Clinical Trials on Alzheimer's Disease Conference
November 2, 2015
ORYZON Raises $19 Million in Private Placement to Advance Therapeutic Programs
October 27, 2015